Mitchell 2012*
| Methods | ||
| Participants | ||
| Interventions | ||
| Outcomes | ||
| Treatment type | ||
| Notes | Treated as an included study in order to contribute to adverse event meta‐analyses; Excluded for efficacy: New for 2016 update. Varenicline was for drinking reduction, not smoking cessation; only followed for 12 weeks. | |
BMI: Body Mass Index (kg/m2) CAR: Continuous Abstinence Rate CO: carbon monoxide COPD: chronic obstructive pulmonary disease CPD: cigarettes per day CQR: continuous quit rate CVD: cardiovascular disease EoT: end of treatment FTND: Fagerström Test for Nicotine Dependence ITT: intention‐to‐treat LOCF: last observation carried forward MA: meta‐analysis MDD: major depressive disorder MI: motivational interviewing mCEQ: Modified Cigarette Evaluation Questionnaire MNWS: Minnesota Nicotine Withdrawal Scale PA prolonged abstinence PPA: point‐prevalence abstinence QoL: quality of life QSU‐brief: Brief Questionnaire of Smoking Urges RCT: randomised controlled trial SAE: serious adverse event SC: smoking cessation TQD: target quit date